欧林生物: 成都欧林生物科技股份有限公司股东减持股份计划公告

Core Viewpoint - The major shareholder of Chengdu Olin Biological Technology Co., Ltd. plans to reduce its stake in the company due to personal funding needs, with a maximum reduction of 12,178,008 shares, accounting for no more than 3% of the total share capital [1][2][3] Shareholder Holding Situation - As of the announcement date, the controlling shareholder, Shanghai Wushan Biotechnology Co., Ltd., holds 72,394,330 shares, representing 17.83% of the total share capital [1][2] - The actual controllers, Fan Shaowen and Fan Fan, control Shanghai Wushan and have committed not to participate in this reduction [1][2] Reduction Plan Details - The reduction will occur within three months after the announcement, starting from 15 trading days post-disclosure [2][3] - The reduction will be executed through centralized bidding or block trading, with a maximum of 4,059,336 shares through centralized bidding and 8,118,672 shares through block trading [2][3] Reason for Reduction - The reduction is primarily due to the need for funding related to investment project exits and financial arrangements [3] Compliance and Commitments - The controlling shareholder has made commitments regarding the reduction, including not proposing a buyback of the shares held prior to the IPO and adhering to specific regulations regarding the timing and volume of share reductions [4][5][6] - The company has confirmed that this reduction will not lead to a change in control or significantly impact its ongoing operations [7]